Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Has results × Interleukin-2 × Clear all

Phase

Phase 2 51 Phase 1/2 17 Phase 1 8 Phase NA 3 Phase 4 2 Phase 3 2

Sponsor

Interventions

pembrolizumab 6 Cyclophosphamide 5 durvalumab 3 Vincristine 3 Radiation 3 Metformin 3 Testosterone 2 Surveys and Questionnaires 2 Rituximab 2 Positron Emission Tomography Computed Tomography 2 Lapatinib 2 Immunoglobulin G 2 Imiquimod 2 Fluorouracil 2 Doxorubicin 2 Disulfides 2 Cisplatin 2 xentuzumab 1 tremelimumab 1 ribociclib 1 posaconazole 1 pexidartinib 1 pazopanib 1 paricalcitol 1 parathyroid hormone-related peptide (1-36) 1 palbociclib 1 oblimersen 1 nilotinib 1 ixazomib 1 infigratinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡